Crossmark

Laboratory evaluations of the 3-month efficacy of oral lotilaner (Credelio™) against experimental infestations of dogs with the Australian paralysis tick, Ixodes holocyclus

Crossref DOI link: https://doi.org/10.1186/s13071-018-3061-8

Published Online: 2018-08-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baker, Kim

Ellenberger, Claudia

Murphy, Martin

Cavalleri, Daniela

Seewald, Wolfgang

Drake, Jason http://orcid.org/0000-0001-6203-0852
Nanchen, Steve

Hacket, Kristina
Funding

Funding for this research was provided by:

Elanco Animal Health
License Information

Text and Data Mining valid from 2018-08-29
More Information

Article History

Received: 14 June 2018

Accepted: 13 August 2018

First Online: 29 August 2018

Ethics approval

: Protocols were approved by the by the Vet Superscript removed Research Animal Ethics Committee and by Novartis Animal Health Ethics Committee. No consent to participate was required.

: Not applicable.

: KB, CE, MM, DC, WS, JD, SN and KH are employees of Elanco Animal Health.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below